Standout Papers

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance 2019 2026 2021 2023 1.5k
  1. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance (2019)
    Filipe Martins, Sofiya Latifyan et al. Nature Reviews Clinical Oncology

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 61 standout
Sub-graph 1 of 21

Citing Papers

Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
2024 Standout
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
4 intermediate papers

Works of Camillo Ribi being referenced

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Eosinophilic esophagitis: latest insights from diagnosis to therapy
2018

Author Peers

Author Last Decade Papers Cites
Camillo Ribi 876 867 959 1395 111 3.2k
James B. Whitmore 735 1503 711 789 63 3.9k
Jan‐Stephan Sanders 404 862 1161 844 164 4.1k
Yan Guex‐Crosier 240 550 480 1203 130 3.4k
Freda Passam 461 644 454 582 95 3.1k
Marco Tucci 648 1337 535 1500 133 4.2k
Gerhard Fierlbeck 440 771 446 1194 96 3.1k
Edward W. Cowen 378 828 408 552 152 3.0k
Thomas Barnetche 1814 1715 268 831 123 4.4k
Yoshitaka Morita 764 993 259 596 103 2.7k
Michael B. Stokes 572 1094 1315 883 106 5.9k

All Works

Loading papers...

Rankless by CCL
2026